News | Heart Valve Technology | July 24, 2023

Allegheny General Hospital Receives Recognition as a Mitral Valve Repair Reference Center from the American Heart Association and the Mitral Foundation

With Only 21 Facilities Achieving this Award Nationally, AGH Ranks Among the Most Elite Mitral Valve Programs in the Country and Only Designated Center in Pennsylvania

With Only 21 Facilities Achieving this Award Nationally, AGH Ranks Among the Most Elite Mitral Valve Programs in the Country and Only Designated Center in Pennsylvania

Allegheny General Hospital, flagship academic medical center of Pittsburgh-based Allegheny Health Network


July 24, 2023 — Allegheny General Hospital (AGH), the flagship academic medical center of Allegheny Health Network (AHN), announced today it has once again received the Mitral Valve Repair Reference Center Award from the American Heart Association (AHA) and the Mitral Foundation for a demonstrated record of superior clinical outcomes resulting from evidence-based, guideline-directed degenerative mitral valve repair. 

This is the third consecutive year AGH and its AHN Cardiovascular Institute team have been recognized as a Mitral Valve Repair Reference Center since the recognition was established in 2019, placing AHN’s program among the most elite nationwide. To date, only 21 facilities have earned this award across the country and AGH remains the only hospital to receive this recognition in Pennsylvania. 

“This award recognizes the commitment of our clinicians and caregivers who provide the highest levels of care to our patients, year after year,” said Walter E. McGregor, MD, lead surgeon of the AHN mitral valve program and director of AHN cardiac surgery at AHN Cardiovascular Institute. “On behalf of the entire Network, I want to extend my sincere gratitude to their tireless work that upholds the AHN Cardiovascular Institute’s longstanding legacy of clinical excellence.” 

The mitral valve is in the left side of the heart and works to keep blood flowing properly in one direction from the left atrium to the left ventricle. When the valve doesn’t work correctly, allowing blood to flow backward, the heart can’t pump enough oxygenated blood for the body. Symptoms of mitral valve regurgitation often include fatigue and shortness of breath. 

Mitral valve repair is considered the gold-standard therapy for degenerative mitral valves and is generally preferred over mitral valve replacement since valve repair is associated with improved survival and fewer long-term complications. Valve replacement with a bioprosthetic or mechanical valve typically has higher five-to-ten-year complication rates compared to repair. 

“We are pleased to recognize Allegheny General Hospital for their commitment to patients who need mitral valve repair,” said Robert O. Bonow, MD, professor of cardiology at Northwestern University and past president of the American Heart Association. “Choosing the right hospital for heart surgery is one of the most important health care decisions that patients and their referring physicians must make to ensure best outcomes. The Mitral Valve Repair Reference Center award identifies hospitals with excellent processes and outcomes and gives patients and cardiologists the information necessary to make these important decisions when mitral valve surgery is required.” 

The Mitral Valve Repair Reference Center Award was developed to identify, recognize and promote the nation’s recognized medical centers for mitral valve repair surgery. AGH earned the award for demonstrating adherence to evidence-based treatment guidelines as well as an ongoing commitment to reporting and measuring quality and outcome metrics specific to mitral valve repairs. 

“This such a meaningful designation as it is contingent on superb outcomes -- 95% repair rate and less than 1% mortality -- in a high volume of patients and verified by the AHA,” said Stephen Bailey, MD, cardiothoracic surgeon and Chair of AHN Cardiovascular Institute. “We’re incredibly proud of today’s recognition as it further establishes our program as a nationally recognized leader in managing and treating complex cardiovascular disease.” 

For more information: www.ahn.org


Related Content

News | Heart Valve Technology

Dec. 26, 2025 — Edwards Lifesciences has announced the company’s SAPIEN M3 mitral valve replacement system, a ...

Home December 24, 2025
Home
News | Heart Valve Technology

Nov. 17, 2025 — Royal Philips has introduced DeviceGuide, an AI-powered device tracking* solution that assists ...

Home November 17, 2025
Home
News | Heart Valve Technology | Cedars-Sinai Medical Center

Oct. 28, 2025 — People who underwent a minimally invasive procedure to have their heart’s aortic valve replaced had ...

Home October 29, 2025
Home
News | Heart Valve Technology

Aug. 28, 2025 — Medtronic plc has announced it received U.S. Food and Drug Administration (FDA) approval for the ...

Home August 29, 2025
Home
News | Heart Valve Technology

Aug. 18, 2025 — A new study published in The Annals of Thoracic Surgery, a journal from The Society of Thoracic Surgeons ...

Home August 19, 2025
Home
News | Heart Valve Technology

Aug. 4, 2025 — Corcym announced that its Perceval Plus sutureless aortic heart valve was used in a first-ever robotic ...

Home August 05, 2025
Home
News | Heart Valve Technology

July 10, 2025 — On July 2, 2025, Centers for Medicare & Medicaid Services (CMS) issued a National Coverage Determination ...

Home July 11, 2025
Home
News | Heart Valve Technology

June 27, 2025 – Foldax Inc., a leader in the development of innovative polymer heart valves, has announced compelling ...

Home June 27, 2025
Home
News | Heart Valve Technology

June 04, 2025 — HeartSciences Inc. has announced that the U.S. Food and Drug Administration has granted Breakthrough ...

Home June 12, 2025
Home
News | Heart Valve Technology

May 27, 2025 — Abbott has announced the U.S. Food and Drug Administration (FDA) has approved the company's Tendyne ...

Home May 28, 2025
Home
Subscribe Now